Jubilant Life Sciences announced a price increase of 10% for Niacinamide, with immediate effect, for non-contract customers and wherever existing contracts permit.

"Jubilant delivers unmatched advantages of consistent quality and availability of Vitamin B3 (Niacin & Niacinamide) to its customers globally.

The company's Nutritional products business is backward integrated up to the initial raw material stage with global scale of operations," the company said.

Shares of the company declined Rs 1.65, or 0.97%, to settle at Rs 168.45. The total volume of shares traded was 83,955 at the BSE (Tuesday).